BILL ANALYSIS �
SB 1301
Page 1
Date of Hearing: August 8, 2012
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Felipe Fuentes, Chair
SB 1301 (Hern�ndez) - As Amended: August 6, 2012
Policy Committee: HealthVote:18-0
Business and Professions Vote: 9-0
Urgency: No State Mandated Local Program:
No Reimbursable: No
SUMMARY
This bill allows a pharmacist to dispense up to a 90-day supply
of a prescribed drug, excluding controlled substances, if the
patient has completed an initial 30-day supply of the drug and
other requirements are satisfied, as specified.
It also specifies it does not require a health care service
plan, health insurer, workers' compensation insurance plan,
pharmacy benefits manager, or any other person or entity,
including, but not limited to, a state program or state
employer, to provide drug coverage in a manner inconsistent with
a beneficiary's plan benefit.
FISCAL EFFECT
Negligible state fiscal effect.
COMMENTS
1)Rationale . The author believes that allowing patients to
receive up to 90 days of a prescription refill will make it
easier for them to adhere to their treatment and live
healthier lives while reducing costs throughout the health
care system. Additionally, he points to consumer benefit from
increased convenience and possible fewer copayments at the
pharmacy. The California Retailers Association is the sponsor
of this measure.
2)Background . Currently, pharmacists must seek authorization
from a prescriber before dispensing more than a 30-day
prescription unless a larger amount is prescribed initially.
SB 1301
Page 2
Retailers report that often, prescribers cannot be reached for
authorization, leaving individuals with only a 30-day supply
which must then be refilled.
Studies have found potential cost savings related to
dispensing larger amounts of certain drugs. Generally, drugs
for which prescription adherence is important, that are
lower-cost per dose, and/or that are related to controlling
chronic conditions are thought to be better candidates for
larger dosages from a health care cost perspective. This bill
does not require health plans to cover a 90-day supply,
suggesting that plans and pharmacy benefit managers would
retain control over which drugs are reimbursed in larger
quantities than 30 days.
Analysis Prepared by : Lisa Murawski / APPR. / (916) 319-2081